Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Genomic Health Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Genomic Health Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Genomic Health Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Genomic Health Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Genomic Health Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Genomic Health Inc, Medical Equipment, Deal Details 12
Venture Financing 12
Epic Sciences Raises USD52 Million in Series E Financing 12
Epic Sciences Raises USD40 Million in Series D Venture Financing 14
InVitae Raises USD120 Million in Series F Venture Financing 16
Invitae Raises US$40 Million In Series E Financing 18
Partnerships 20
Genomic Health Enters into Licensing Agreement with Cleveland Diagnostics 20
Genomic Health Enters into Licensing Agreement with Biocartis 21
New England Biolabs Enters into Licensing Agreement with Genomic Health for Ribosomal RNA Depletion Technology 22
Genomic Health Enters Into In-Licensing Agreement With Almac To Develop And Commercialize Anthracycline Chemotherapy Benefit Test 23
NewBridge Pharma Enters Into Licensing Agreement With Genomic Health For Oncotype DX Tests 25
Genomic Health Enters into Research Agreement with Janssen Pharma 26
Genomic Health and Epic Sciences Enter into Distribution Agreement 27
Philips Electronics Enters into Agreement with Genomic Health 28
Specialised Therapeutics Enters Into Distribution Agreement With Genomic Health For Oncotype DX Test 29
Genomic Health Enters Into Co-Development Agreement With OncoMed Pharma 30
Equity Offering 31
Biocartis Group Raises USD4 Million in Private Placement 31
Genomic Health Files Registration Statement For Public Offering Of Shares To Raise Up To US$334 Million 32
Genomic Health Inc – Key Competitors 33
Genomic Health Inc – Key Employees 34
Genomic Health Inc – Locations And Subsidiaries 35
Head Office 35
Other Locations & Subsidiaries 35
Recent Developments 36
Financial Announcements 36
Aug 02, 2018: Genomic Health reports second quarter 2018 financial results 36
May 02, 2018: Genomic Health Reports First Quarter 2018 Financial Results 38
Mar 08, 2018: Genomic Health Announces 2017 Fourth Quarter and Year-end Financial Results, Provides 2018 Financial Outlook 40
Nov 08, 2017: Genomic Health Announces Third Quarter 2017 Financial Results and Reports Recent Business Progress 42
Aug 01, 2017: Genomic Health Announces Second Quarter 2017 Financial Results and Reports Recent Business Progress 44
May 09, 2017: Genomic Health Announces First Quarter 2017 Financial Results and Reports Recent Business Progress 46
Feb 14, 2017: Genomic Health Announces 2016 Fourth Quarter and Year-End Financial Results, Provides 2017 Financial Outlook 48
Product News 50
Jun 02, 2017: Genomic Health Presents Data Further Demonstrating Ability of Oncotype DX Tests to Optimize Outcomes in Patients Across Cancer Types 50
May 30, 2017: Genomic Health Announces Presentation of Eight Oncotype DX Studies at the 2017 American Society of Clinical Oncology Annual Meeting Reinforcing Unique Impact Across Cancer Types 52
Appendix 55
Methodology 55
About GlobalData 55
Contact Us 55
Disclaimer 55
Genomic Health Inc, Medical Equipment, Key Facts, 2017 2
Genomic Health Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Genomic Health Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Genomic Health Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Genomic Health Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Genomic Health Inc, Deals By Market, 2012 to YTD 2018 9
Genomic Health Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Epic Sciences Raises USD52 Million in Series E Financing 12
Epic Sciences Raises USD40 Million in Series D Venture Financing 14
InVitae Raises USD120 Million in Series F Venture Financing 16
Invitae Raises US$40 Million In Series E Financing 18
Genomic Health Enters into Licensing Agreement with Cleveland Diagnostics 20
Genomic Health Enters into Licensing Agreement with Biocartis 21
New England Biolabs Enters into Licensing Agreement with Genomic Health for Ribosomal RNA Depletion Technology 22
Genomic Health Enters Into In-Licensing Agreement With Almac To Develop And Commercialize Anthracycline Chemotherapy Benefit Test 23
NewBridge Pharma Enters Into Licensing Agreement With Genomic Health For Oncotype DX Tests 25
Genomic Health Enters into Research Agreement with Janssen Pharma 26
Genomic Health and Epic Sciences Enter into Distribution Agreement 27
Philips Electronics Enters into Agreement with Genomic Health 28
Specialised Therapeutics Enters Into Distribution Agreement With Genomic Health For Oncotype DX Test 29
Genomic Health Enters Into Co-Development Agreement With OncoMed Pharma 30
Biocartis Group Raises USD4 Million in Private Placement 31
Genomic Health Files Registration Statement For Public Offering Of Shares To Raise Up To US$334 Million 32
Genomic Health Inc, Key Competitors 33
Genomic Health Inc, Key Employees 34
Genomic Health Inc, Other Locations 35
Genomic Health Inc, Subsidiaries 35
List of Figures
Genomic Health Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Genomic Health Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Genomic Health Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Genomic Health Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Genomic Health Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Genomic Health Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Genomic Health Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Genomic Health Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9